Comparison
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078 vs 3q13 Microdeletion Syndrome C2931338
Clinical comparison between 46 XX Disorder OF Sex Development Anorectal Anomalies Syndrome and 3q13 Microdeletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
A rare genetic syndrome affecting an XX individual, causing both differences in sexual development and anal-rectal abnormalities. It is congenital and severe. Surgical correction and long-term specialist care are typically required.
3q13 Microdeletion Syndrome C2931338
A genetic disorder from missing material on chromosome 3q13, associated with developmental delays, intellectual disability, and various congenital features.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
0-0
3q13 Microdeletion Syndrome C2931338
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
severe
3q13 Microdeletion Syndrome C2931338
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
Chronic
3q13 Microdeletion Syndrome C2931338
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
No
3q13 Microdeletion Syndrome C2931338
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
reproductive
3q13 Microdeletion Syndrome C2931338
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
rare-disease
3q13 Microdeletion Syndrome C2931338
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-anorectal-anomalies-syndrome-C4518078 and 3q13-microdeletion-syndrome-C2931338 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078 | 3q13 Microdeletion Syndrome C2931338 | Discriminating power |
|---|---|---|---|
| Genital and sex development | Source describes differences of sex development in an XX individual. | Not specifically described; congenital features are variable. | High |
| Anorectal anatomy | Anal-rectal abnormalities are a defining described feature. | Not established as a characteristic feature from the supplied source. | High |
| Neurodevelopment | Developmental delay or intellectual disability is not established here. | Associated with developmental delay and intellectual disability. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078 when
XX infant with both genital differences and anorectal anomaly
This combination matches the supplied syndrome description.
Moderate
Congenital severe reproductive and anorectal findings
The source characterizes the condition as congenital and severe.
Moderate
Need for coordinated surgical and specialist follow-up
Surgical correction and long-term specialist care are typically described.
Moderate
Choose 3q13 Microdeletion Syndrome C2931338 when
Confirmed missing material at chromosome 3q13
The diagnosis is defined by the chromosomal deletion.
High
Developmental delay with intellectual disability
These are the principal associations in the supplied description.
Moderate
Variable congenital features without the specific XX-anorectal pattern
The source supports a broader congenital presentation.
Low
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078 | 3q13 Microdeletion Syndrome C2931338 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome assessment | XX context is part of the named condition. | Sex-chromosome result is not specified by the source. | An XX result alone does not establish either diagnosis. |
| Chromosomal microarray | A specific deletion is not established in the supplied data. | Expected to identify missing 3q13 material. | Genetic confirmation is required for the microdeletion diagnosis. |
| Anorectal and genital examination or imaging | May document anorectal and sex-development differences. | Findings are variable and not specifically defined here. | Abnormal anatomy supports evaluation but is not itself a genetic diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Anorectal Anomalies Syndrome C4518078
- Outcome
- Chronic and severe based on the source, but individual outcome is not established.
- Factors
- Anorectal anatomy, sex-development findings, surgical needs, and specialist follow-up.
3q13 Microdeletion Syndrome C2931338
- Outcome
- Chronic with moderate source severity; developmental course varies.
- Factors
- Extent of 3q13 deletion, developmental profile, and associated congenital features.
Time frame: Congenital onset for the left; variable recognition for the right, with lifelong follow-up possible.
No reliable mortality or quality outcome data are supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Surgical and anatomical complications | Anorectal and genital differences may require correction. Specific surgical complications are not established. Complication rates are not supplied. |
| Developmental complications | Not established from the available description. Developmental delay and intellectual disability are associated. Severity and trajectory require individual assessment. |
| Long-term multisystem needs | Long-term specialist care is typically described. Variable congenital features may need ongoing evaluation. Neither source establishes exact outcomes or mortality. |
Patient education highlights
- HighDiagnosis confirmation
These are distinct genetic conditions; testing and clinician review are needed before assigning either diagnosis.
- HighCare planning
The left condition typically involves surgical and specialist care; the right centers on developmental and congenital needs.
- MediumUncertainty
Available descriptions do not establish prevalence, exact test cutoffs, treatment doses, or prognosis.